Login/Sign Up
Online payment accepted
Provide Delivery Location
Whats That
Therapeutic Class
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Rybelsus 3 mg Tablet contains semaglutide. Semaglutide is a GLP-1 hormone that enhances glycemic control through various mechanisms, including insulin secretion, slowing gastric emptying, and decreasing postprandial glucagon secretion. This drug is frequently paired with dietary and exercise changes. Altogether Rybelsus 3 mg Tablet reduces sugar levels in the body.
Low blood glucose levels are referred to as hypoglycaemia. Rybelsus 3 mg Tablet may result in hypoglycaemia. Hypoglycaemia can occur if you skip or delay eating, drink alcohol, exercise strenuously, or take other diabetes medications in addition to Rybelsus 3 mg Tablet .
Do not stop taking Rybelsus 3 mg Tablet without first consulting your doctor. Take Rybelsus 3 mg Tablet for as long as the doctor has instructed. Consult a doctor if you have any problems while taking Rybelsus 3 mg Tablet .
Take the missed dose as soon as you remember. If it is time for the next scheduled dose, skip the missing dose and resume your regular dosing regimen. Do not double the dose.
Caution should be exercised if you have severe and ongoing pain in the stomach area. It is recommended to consult a doctor immediately, as this could signify an inflamed pancreas (acute pancreatitis). Your doctor will weigh the benefits and potential risks before prescribing this medication.
Rybelsus 3 mg Tablet is not recommended to treat type 1 diabetes (your body produces no insulin).
Rybelsus 3 mg Tablet should not use if you have type 1 diabetes or diabetic ketoacidosis or if you are allergic to Semaglutide or any of the other ingredients of this medicine.
Alcohol
Unsafe
It is advised to avoid alcohol intake since it may worsen the side effects like lactic acidosis and increase the risk of developing low blood sugar levels.
Pregnancy
Caution
Rybelsus 3 mg Tablet is not recommended during pregnancy, as it is unknown if it affects your unborn baby. Please discuss this with your doctor if you have any concerns regarding this.
Breast Feeding
Caution
Rybelsus 3 mg Tablet should not be used if you are breastfeeding because it is unknown whether it goes into breast milk. Please discuss this with your doctor if you have any concerns regarding this.
Driving
Caution
Caution should be exercised. If your blood sugar is too low or too high, your driving ability may be affected. Do not drive if these symptoms appear.
Liver
Caution
Limited information was available for the use of Rybelsus 3 mg Tablet in patients suffering from liver impairment. Please consult your doctor if you have any concerns regarding using Rybelsus 3 mg Tablet in patients with liver impairment. Your doctor will prescribe only if the benefits outweigh the risks.
Kidney
Caution
Caution should be exercised in people with kidney impairment while using Rybelsus 3 mg Tablet . Inform your doctor before receiving the Rybelsus 3 mg Tablet if you have had a kidney impairment/disorder history. Your doctor will prescribe only if the benefits outweigh the risks.
Children
Unsafe
Rybelsus 3 mg Tablet is not indicated for children and adolescents under 18 since the safety and efficacy in this age range have not been verified.
About Rybelsus 3 mg Tablet
Rybelsus 3 mg Tablet belongs to the class of medications called 'anti-diabetic agents' used to improve glycaemic control in adult patients with type 2 diabetes mellitus when diet and exercise are not enough or when the other medicines are not enough to control your blood sugar levels. Type 2 diabetes is a condition in which your body does not produce enough insulin, and the insulin produced does not drop your blood sugar as effectively as it could.
Rybelsus 3 mg Tablet comprises semaglutide. Semaglutide is a GLP-1 physiological hormone that promotes glycemic control via several mechanisms, including insulin secretion, slowing gastric emptying, and reducing postprandial glucagon secretion. Changes to diet and exercise are often combined with this medication.
Take Rybelsus 3 mg Tablet as prescribed. You are advised to take Rybelsus 3 mg Tablet for as long as your doctor has advised. In some cases, Rybelsus 3 mg Tablet may cause diabetic eye disease (retinopathy), feeling sick (nausea) or being sick (vomiting), diarrhoea, low blood sugar (hypoglycaemia), upset stomach or indigestion and inflamed stomach ('gastritis'). Most of these side effects do not require medical attention and will resolve gradually over time. However, if the side effects persist or worsen, consult your doctor.
It is recommended not to take Rybelsus 3 mg Tablet if you are allergic to any of its components. You should inform your doctor if you get eye problems. If you have significant and ongoing stomach pain, consult a doctor immediately, as this could be a sign of an inflamed pancreas (acute pancreatitis). Avoiding alcohol is recommended to rule out any risk of lactic acidosis or other complications. Rybelsus 3 mg Tablet is not recommended to use in a pregnant woman or nursing mother, or children below 18 years of age. If you become pregnant while using this medication, contact your doctor immediately since your treatment will need to be modified. Caution should be exercised. If your blood sugar is too low or too high, your driving ability may be affected. Do not drive if these symptoms appear.
Uses of Rybelsus 3 mg Tablet
Medicinal Benefits
Rybelsus 3 mg Tablet is used to treat type 2 diabetes in people 18 years and older. It is used when diet and exercise are not enough on their own or cannot use another diabetes medicine or when the other drugs are not enough to control or maintain your blood sugar levels. Rybelsus 3 mg Tablet comprises semaglutide. Semaglutide is a GLP-1 physiological hormone that promotes glycemic control via several mechanisms, including insulin secretion, slowing gastric emptying, and reducing postprandial glucagon secretion. Changes to diet and exercise are often combined with this medication.
Directions for Use
Side Effects of Rybelsus 3 mg Tablet
Drug Warnings
It is recommended not to take Rybelsus 3 mg Tablet if you are allergic to any of its components. You should inform your doctor if you get eye problems, such as changes in vision, during treatment with this medicine as the Rybelsus 3 mg Tablet may lead to complications of diabetic eye disease (retinopathy). When taking this medication, you may feel nauseous (nausea), sick (vomiting), or have diarrhoea. These adverse effects may result in dehydration (loss of fluids). You must consume enough water to avoid dehydration, especially if you have kidney issues. If you have any questions or concerns, consult your doctor. If you have significant and ongoing stomach pain, consult a doctor immediately, as this could be a sign of an inflamed pancreas (acute pancreatitis). Avoiding alcohol is recommended to rule out any risk of lactic acidosis or other complications. Rybelsus 3 mg Tablet is not recommended for pregnant women, nursing mothers, or people below 18 years of age. If you become pregnant while taking this medication, contact your doctor immediately since your treatment will need to be modified.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
Login/Sign Up
Drug-Drug Interactions Checker List
Habit Forming
Special Advise
Diet & Lifestyle Advise
Have a query?
Buy best Diabetics products by
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Eris Life Sciences Ltd
Intas Pharmaceuticals Ltd
Lupin Ltd
Micro Labs Ltd
Mankind Pharma Pvt Ltd
Lloyd Healthcare Pvt Ltd
Alkem Laboratories Ltd
Abbott India Ltd
Glenmark Pharmaceuticals Ltd
Cipla Ltd
Macleods Pharmaceuticals Ltd
Wockhardt Ltd
Dr Reddy's Laboratories Ltd
Primus Remedies Pvt Ltd
USV Pvt Ltd
Aristo Pharmaceuticals Pvt Ltd
Emcure Pharmaceuticals Ltd
Alembic Pharmaceuticals Ltd
Ipca Laboratories Ltd
La Renon Healthcare Pvt Ltd
Ajanta Pharma Ltd
Medley Pharmaceuticals Ltd
East West Pharma India Pvt Ltd
Elbrit Life Sciences Pvt Ltd
Corona Remedies Pvt Ltd
Hbc Life Sciences Pvt Ltd
Sinsan Pharmaceuticals Pvt Ltd
Ranmarc Labs
Mitoch Pharma Pvt Ltd
Zydus Healthcare Ltd
Sanofi India Ltd
Akumentis Healthcare Ltd
Fusion Health Care Pvt Ltd
Unison Pharmaceuticals Pvt Ltd
Jubilant Lifesciences Ltd
Novo Nordisk India Pvt Ltd
Tas Med India Pvt Ltd
Blue Cross Laboratories Pvt Ltd
Msn Laboratories Pvt Ltd
Eswar Therapeutics Pvt Ltd
Indoco Remedies Ltd
Q Check Pharmaceuticals
Alteus Biogenics Pvt Ltd
Anthem Bio Pharma
Franco Indian Pharmaceuticals Pvt Ltd
Systopic Laboratories Pvt Ltd
Panacea Biotec Ltd
Zydus Cadila
Biocon Ltd
Edoc Life Sciences Pvt Ltd
Koye Pharmaceuticals Pvt Ltd
Arkas Pharma Pvt Ltd
Diacardus Pharmacy Pvt Ltd
Elinor Pharmaceuticals (P) Ltd
Remedy Life Sciences Pvt Ltd
Saan Labs
Talent India Pvt Ltd
Jarun Pharmaceuticals Pvt Ltd
Capital Pharma
Shrrishti Health Care Products Pvt Ltd
FDC Ltd
Leeford Healthcare Ltd
Nirvana India Pvt Ltd
Elder Pharmaceuticals Ltd
Eli Lilly and Company (India) Pvt Ltd
Glynis Pharmaceuticals Pvt Ltd
Zuventus Healthcare Ltd
Arrient Healthcare Pvt Ltd
Cadomed Pharmaceuticals India Pvt Ltd
Orris Pharmaceuticals
Akesiss Pharma Pvt Ltd
Bal Pharma Ltd
Biochem Pharmaceutical Industries Ltd
Knoll Healthcare Pvt Ltd
Lippon Pharma Pvt Ltd
Morepen Laboratories Ltd
Neucure Lifesciences Pvt Ltd
Opsis Care Lifesciences Pvt Ltd
Wallace Pharmaceuticals Pvt Ltd
Acmedix Pharma Llp
Converge Biotech Pvt Ltd
Erinyle Pharma
Indiabulls Pharmaceuticals Pvt Ltd
Ozone Pharmaceuticals Ltd
Retra Life Science Pvt Ltd
Alvio Pharmaceuticals Pvt Ltd
Geneaid Pharmaceuticals
Heal (India) Laboratories Pvt Ltd
Olcare Laboratories Pvt Ltd
Vasu Organics Pvt Ltd
Kotak Life Sciences
Lakshya Life Sciences Pvt Ltd
Proqol Health Care Pvt Ltd
Sanz Pharmaceuticals
Daylon healthcare pvt Ltd
Mcronus Lifescience Pvt Ltd
Natco Pharma Ltd
Orsim Pharma
Customers Also Bought
Recommended for a 30-day course: 3 Strips